Skip to content

Abnormal Oct Measured Foveal Thickness C4073087

Published: July 22, 2026Updated: August 26, 2026

A measurement finding from eye imaging showing the fovea (central retina) is thicker or thinner than normal. It may indicate macular disease and warrants ophthalmology evaluation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Metamorphopsia (wavy or distorted vision)

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Reduced best-corrected visual acuity

(ophthalmologic)

Central scotoma (central blind spot)

(ophthalmologic)

Difficulty reading small print

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Intravitreal anti-VEGF therapy

Anti-vascular endothelial growth factor medications are injected into the eye to reduce abnormal blood vessel growth and fluid accumulation that contributes to foveal thickness abnormalities. Regular follow-up injections are typically required to maintain therapeutic effect.

medication
3

Optical coherence tomography monitoring

Serial OCT imaging tracks changes in foveal thickness over time, allowing clinicians to assess disease progression and response to treatment interventions. Quantitative measurements guide clinical decision-making regarding treatment escalation or modification.

procedure

Additional treatment options

Intravitreal corticosteroid injection

Corticosteroid medications reduce inflammation and vascular permeability that may contribute to abnormal foveal thickness. This treatment is often considered when anti-VEGF therapy is ineffective or poorly tolerated.

medication

Focal laser photocoagulation

Targeted laser treatment seals leaking blood vessels in the macula that may be contributing to foveal thickness changes. This older but established technique remains useful for certain types of macular edema.

procedure

Vitrectomy with membrane peeling

Surgical removal of the vitreous gel and epiretinal membranes may be necessary when tractional components contribute to foveal thickness abnormalities. This procedure is reserved for cases with significant structural distortion.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Oct Measured Foveal Thickness C4073087?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2023;130(5):423-432.

guideline2023
2

Sadda SR, Wu Z, Walsh AC, et al. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology. 2018;125(8):1231-1241.

review2018
3

Brown DM, Nguyen TD, Marcus DM, et al. Long-term outcomes of ranibizumab therapy for diabetic macular edema. N Engl J Med. 2019;381(16):1528-1538.

clinical_trial2019
4

Keane PA, Sadda SR. Predicting visual outcomes for macular disease using optical coherence tomography. JAMA Ophthalmol. 2021;139(5):528-538.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Abnormal Oct Measured Foveal Thickness C4073087. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy